Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Untch

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Gynakologisch-Geburtshilfliche Rundschau|April 10, 2004
[Minimally invasive biopsy and preoperative marking of suspect mammary lesions]H Sittek, M Kessler, M Untch, et al.
Clinical Breast Cancer|June 18, 2005
Overview of epirubicin-based adjuvant therapy in breast cancerM Untch, F von Koch, S Kahlert, et al.
Gynakologisch-Geburtshilfliche Rundschau|April 10, 2004
[Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results]S Kahlert, F von Koch, N Ditsch, et al.
Gynakologisch-Geburtshilfliche Rundschau|April 10, 2004
[Neoadjuvant therapy of breast cancer]I Rühl, I Bauerfeind, S Kahlert, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labelling for identification of tumour cellsR Kimmig, T Kapsner, H Spelsberg, et al.
Gynakologisch-Geburtshilfliche Rundschau|April 28, 2001
[Retrospective analysis of dose intensity of epirubicin in breast cancer]G Konecny, M Frank, S Kahlert, et al.
Oncology Reports|May 19, 2011
Urokinase-type plasminogen activator and its inhibitor plasminogen activator inhibitor-1B Wollenberg, N Jan, R Jund, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|October 1, 1994
Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cellsR Kimmig, H Spelsberg, T Kapsner, et al.
Expert Opinion on Biological Therapy|June 15, 2005
A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumabS Rueckert, I Ruehl, S Kahlert, et al.
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|October 30, 1998
[Dynamic MR-mammography in invasive lobular breast cancer]H Sittek, C Perlet, M Untch, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Gynakologisch-Geburtshilfliche Rundschau|April 10, 2004
[Minimally invasive biopsy and preoperative marking of suspect mammary lesions]H Sittek, M Kessler, M Untch, et al.
Clinical Breast Cancer|June 18, 2005
Overview of epirubicin-based adjuvant therapy in breast cancerM Untch, F von Koch, S Kahlert, et al.
Gynakologisch-Geburtshilfliche Rundschau|April 10, 2004
[Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results]S Kahlert, F von Koch, N Ditsch, et al.
Gynakologisch-Geburtshilfliche Rundschau|April 10, 2004
[Neoadjuvant therapy of breast cancer]I Rühl, I Bauerfeind, S Kahlert, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labelling for identification of tumour cellsR Kimmig, T Kapsner, H Spelsberg, et al.
Gynakologisch-Geburtshilfliche Rundschau|April 28, 2001
[Retrospective analysis of dose intensity of epirubicin in breast cancer]G Konecny, M Frank, S Kahlert, et al.
Oncology Reports|May 19, 2011
Urokinase-type plasminogen activator and its inhibitor plasminogen activator inhibitor-1B Wollenberg, N Jan, R Jund, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|October 1, 1994
Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cellsR Kimmig, H Spelsberg, T Kapsner, et al.
Expert Opinion on Biological Therapy|June 15, 2005
A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumabS Rueckert, I Ruehl, S Kahlert, et al.
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|October 30, 1998
[Dynamic MR-mammography in invasive lobular breast cancer]H Sittek, C Perlet, M Untch, et al.
Pageof 17